肝硬化患者的衰弱、肌肉减少症和营养不良。
Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients.
机构信息
Department of Medicine, University of California at Los Angeles, UCLA Medical Center, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90095, USA. Electronic address: https://twitter.com/lizabmn47.
Department of Medicine, University of California at Los Angeles, UCLA Medical Center, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90095, USA; Department of Surgery, University of California at Los Angeles, Los Angeles, CA, USA.
出版信息
Clin Liver Dis. 2019 Nov;23(4):589-605. doi: 10.1016/j.cld.2019.06.001. Epub 2019 Aug 21.
Sarcopenia, frailty, and malnutrition are prevalent complications in patients with end-stage liver disease (ESLD) and are associated with increased risk of morbidity and mortality. It is valuable to measure nutritional status, sarcopenia, and frailty over time in order to create interventions tailored to individuals with ESLD. Evaluating sarcopenia and frailty in patients with ESLD is challenging. Further work is needed to perfect these assessments so that clinicians can incorporate these assessments into their decision-making and management plans for cirrhotic patients.
肌肉减少症、虚弱和营养不良是终末期肝病（ESLD）患者常见的并发症，与发病率和死亡率的增加相关。随着时间的推移测量营养状况、肌肉减少症和虚弱程度，以便为 ESLD 患者制定个体化干预措施是有价值的。评估 ESLD 患者的肌肉减少症和虚弱程度具有挑战性。需要进一步努力完善这些评估，以便临床医生能够将这些评估纳入他们对肝硬化患者的决策和管理计划中。
Zotero 插件